本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

43.63
-0.9900-2.22%
盤後43.630.00000.00%19:30 EDT
成交量:296.96萬
成交額:1.30億
市值:47.38億
市盈率:-23.58
高:45.02
開:44.69
低:42.61
收:44.62
52周最高:48.40
52周最低:13.85
股本:1.09億
流通股本:8,817.09萬
量比:2.81
換手率:3.37%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
淨資產收益率:-38.03%
總資產收益率:-25.03%
市淨率:10.57
市盈率(LYR):-26.76

資料載入中...

2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/08

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/05

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933